用于调节角膜血管生成、淋巴管生成和神经修复的细胞外囊泡的靶点特性及治疗潜力
Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair.
作者信息
Pedersen Cameron, Chen Victoria T, Herbst Paula, Zhang Runze, Elfert Amr, Krishan Abhi, Azar Dimitri T, Chang Jin-Hong, Hu Wen-Yang, Kremsmayer Tobias P, Jalilian Elmira, Djalilian Ali R, Guaiquil Victor H, Rosenblatt Mark I
机构信息
Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
University of Illinois Cancer Center, Chicago, IL, USA.
出版信息
Ocul Surf. 2024 Oct;34:459-476. doi: 10.1016/j.jtos.2024.10.005. Epub 2024 Oct 18.
Extracellular vesicles, including exosomes, are small extracellular vesicles that range in size from 30 nm to 10 μm in diameter and have specific membrane markers. They are naturally secreted and are present in various bodily fluids, including blood, urine, and saliva, and through the variety of their internal cargo, they contribute to both normal physiological and pathological processes. These processes include immune modulation, neuronal synapse formation, cell differentiation, cancer metastasis, angiogenesis, lymphangiogenesis, progression of infectious disease, and neurodegenerative disorders like Alzheimer's and Parkinson's disease. In recent years, interest has grown in the use of exosomes as a potential drug delivery system for various diseases and injuries. Importantly, exosomes originating from a patient's own cells exhibit minimal immunogenicity and possess remarkable stability along with inherent and adjustable targeting capabilities. This review explores the roles of exosomes in angiogenesis, lymphangiogenesis, and nerve repair with a specific emphasis on these processes within the cornea. Furthermore, it examines exosomes derived from specific cell types, discusses the advantages of exosome-based therapies in modulating these processes, and presents some of the most established methods for exosome isolation. Exosome-based treatments are emerging as potential minimally invasive and non-immunogenic therapies that modulate corneal angiogenesis and lymphangiogenesis, as well as enhance and accelerate endogenous corneal nerve repair.
细胞外囊泡,包括外泌体,是直径范围为30纳米至10微米的小型细胞外囊泡,具有特定的膜标记物。它们是自然分泌的,存在于包括血液、尿液和唾液在内的各种体液中,并且通过其内部多种物质,它们对正常生理和病理过程都有贡献。这些过程包括免疫调节、神经元突触形成、细胞分化、癌症转移、血管生成、淋巴管生成、传染病进展以及诸如阿尔茨海默病和帕金森病等神经退行性疾病。近年来,人们越来越关注将外泌体用作各种疾病和损伤的潜在药物递送系统。重要的是,源自患者自身细胞的外泌体表现出最小的免疫原性,具有显著的稳定性以及固有的和可调节的靶向能力。本综述探讨了外泌体在血管生成、淋巴管生成和神经修复中的作用,特别强调角膜内的这些过程。此外,它研究了源自特定细胞类型的外泌体,讨论了基于外泌体的疗法在调节这些过程中的优势,并介绍了一些最成熟的外泌体分离方法。基于外泌体的治疗正在成为潜在的微创和非免疫原性疗法,可调节角膜血管生成和淋巴管生成,以及增强和加速内源性角膜神经修复。
相似文献
Lymphat Res Biol. 2008
Invest Ophthalmol Vis Sci. 2017-3-1
引用本文的文献
J Nanobiotechnology. 2025-8-11
本文引用的文献
Int J Mol Sci. 2024-2-27
Cell Mol Neurobiol. 2024-2-19
J Extracell Vesicles. 2024-2
Nat Biotechnol. 2024-11
Int J Mol Sci. 2023-10-20
Invest Ophthalmol Vis Sci. 2023-10-3
Int J Mol Sci. 2023-6-30